Correlation Between Regal Funds and Bio Gene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regal Funds and Bio Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regal Funds and Bio Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regal Funds Management and Bio Gene Technology, you can compare the effects of market volatilities on Regal Funds and Bio Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regal Funds with a short position of Bio Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regal Funds and Bio Gene.

Diversification Opportunities for Regal Funds and Bio Gene

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Regal and Bio is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Regal Funds Management and Bio Gene Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Gene Technology and Regal Funds is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regal Funds Management are associated (or correlated) with Bio Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Gene Technology has no effect on the direction of Regal Funds i.e., Regal Funds and Bio Gene go up and down completely randomly.

Pair Corralation between Regal Funds and Bio Gene

Assuming the 90 days trading horizon Regal Funds Management is expected to generate 0.34 times more return on investment than Bio Gene. However, Regal Funds Management is 2.98 times less risky than Bio Gene. It trades about 0.15 of its potential returns per unit of risk. Bio Gene Technology is currently generating about -0.23 per unit of risk. If you would invest  378.00  in Regal Funds Management on September 8, 2024 and sell it today you would earn a total of  22.00  from holding Regal Funds Management or generate 5.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Regal Funds Management  vs.  Bio Gene Technology

 Performance 
       Timeline  
Regal Funds Management 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Regal Funds Management are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain essential indicators, Regal Funds unveiled solid returns over the last few months and may actually be approaching a breakup point.
Bio Gene Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Bio Gene is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Regal Funds and Bio Gene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regal Funds and Bio Gene

The main advantage of trading using opposite Regal Funds and Bio Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regal Funds position performs unexpectedly, Bio Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Gene will offset losses from the drop in Bio Gene's long position.
The idea behind Regal Funds Management and Bio Gene Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets